Authors: Roberts, RA James, NH Hasmall, SC Holden, PR Lambe, K Macdonald, N West, D Woodyatt, NJ Whitecome, D

Citation: Ra. Roberts et al., Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPAR alpha, TOX LETT, 112, 2000, pp. 49-57

Authors: Holden, PR Hasmall, SC James, NH West, DR Brindle, RD Gonzalez, FJ Peters, JM Roberts, RA

Citation: Pr. Holden et al., Tumour necrosis factor alpha (TNF alpha): Role in suppression of apoptosisby the peroxisome proliferator nafenopin, CELL MOL B, 46(1), 2000, pp. 29-39

Authors: Holden, PR Tugwood, JD

Citation: Pr. Holden et Jd. Tugwood, Peroxisome proliferator-activated receptor alpha: Role in rodent liver cancer and species differences, J MOL ENDOC, 22(1), 1999, pp. 1-8

Authors: West, DA James, NH Cosulich, SC Holden, PR Brindle, R Rolfe, M Roberts, RA

Citation: Da. West et al., Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptorin the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin, HEPATOLOGY, 30(6), 1999, pp. 1417-1424

Authors: Macdonald, N Holden, PR Roberts, RA

Citation: N. Macdonald et al., Addition of peroxisome proliferator-activated receptor alpha to guinea pighepatocytes confers increased responsiveness to peroxisome proliferators, CANCER RES, 59(19), 1999, pp. 4776-4780

Authors: James, NH Gill, JH Brindle, R Woodyatt, NJ Macdonald, N Rolfe, M Hasmall, SC Tugwood, JD Holden, PR Roberts, RA

Citation: Nh. James et al., Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis, TOX LETT, 103, 1998, pp. 91-96